SCHEMBL2049583

SCHEMBL2049583

CC(Nc1ncnc2[nH]cnc12)c1cc2ncccc2nc1-c1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 13/20 0.45
PIK3CG P48736 8/20 0.45
PIK3R2 O00459 3/20 0.45
PIK3CA P42336 2/20 0.45
PIK3CB P42338 2/20 0.45
DYRK1A Q13627 2/20 0.43
EGFR P00533 1/20 0.36
PIK3R1 P27986 1/20 0.35
MEN1 O00255 1/20 0.35
GBA1 P04062 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPK14 Q16539 1/20 0.35
MBNL1 Q9NR56 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2049588 0.86 PIK3CG (0.48) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL1991283 0.84 PIK3CD (0.52) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL1988679 0.81 PIK3CD (0.61) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL1989608 0.81 PIK3CD (0.61) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL1989504 0.81 PIK3CD (0.61) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL4184362 0.81 PIK3CD (0.55) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL27802807 0.81 PIK3CD (0.55) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL2016174 0.79 PIK3CD (0.54) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL10285585 0.77 PIK3CD (0.59) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB
SCHEMBL10285587 0.77 PIK3CD (0.59) PIK3CDPIK3CGPIK3R2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513109-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2012-10-24 EP disclosed
WO-2011075628-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2011-06-23 WO disclosed